Clinical trials recruiting in Skopje, North Macedonia

Phase breakdown

Conditions recruiting in Skopje, North Macedonia

Recruiting trials in Skopje, North Macedonia

• A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
  NCT07503873 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
  NCT06932081 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
  NCT06823466 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Skopje, North Macedonia?

3 recruiting trials have at least one study site in Skopje, North Macedonia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.